Pain SciencePain MechanismsAdvanced LevelProfessionals
Neuropathic Pain: Screening, Differential Diagnosis and Function-Focused Care
A practical, evidence-informed guide to neuropathic pain: screening, differential diagnosis and function-focused care, with safety screening, clinical reasoning, intervention progression and outcome-based reassessment.
11 October 20269–12 min readEvidence sources included
What You Should Be Able to Explain After Reading
- Define neuropathic pain and distinguish it from nociceptive or nociplastic mechanisms.
- Interpret sensory symptoms, neurological findings and screening questionnaires.
- Plan safe functional rehabilitation with appropriate medical collaboration.
Mechanism without oversimplification
- Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system. Burning, electric shocks, allodynia or altered sensation may suggest it but are not diagnostic alone.
- Peripheral neuropathy, postherpetic neuralgia and nerve-root disease have different causes and treatment pathways.
History and distribution
- Map pain and sensory change against a plausible neuroanatomical distribution; ask about diabetes, shingles, trauma, surgery, chemotherapy, neurological disease and sleep.
- Ask about sensory loss as well as painful hypersensitivity, because a mixture of positive and negative signs can be informative.
Examination and measures
- Assess light touch, pinprick when competent, reflexes, myotomal strength, neurodynamic tolerance and functional tasks where relevant.
- DN4 or painDETECT may support screening but cannot confirm the lesion; use NPRS, pain interference, sleep and patient-specific function to monitor response.
Differential diagnosis
- Nociceptive tissue pain, nociplastic pain, vascular problems and mechanical entrapment may overlap. A clear anatomical and clinical story is more persuasive than one questionnaire score.
- New rapidly progressive weakness, bowel/bladder dysfunction, saddle anesthesia or acute focal neurological deficit requires urgent evaluation.
Management reasoning
- Explain the suspected mechanism without suggesting pain is imaginary or that nerves are permanently damaged. Coordinate medical assessment and evidence-based medication decisions with the prescribing clinician.
- Target tolerable activity, sleep routines, pacing, graded functional exposure and condition-specific strengthening; support self-efficacy and meaningful goals.
Dosage and progression
- Begin with a baseline the patient can repeat without prolonged flare, for example 5–10 minutes of comfortable walking or gentle task practice, then progress one variable at a time.
- Sensory desensitization may be trialed for selected allodynia presentations, with consent and low intensity; monitor tolerability rather than forcing painful exposure.
Precautions and outcomes
- Avoid aggressive nerve tensioning in irritable neuropathic presentations. Reassess neurological signs if symptoms spread or motor function declines.
- Track both symptom burden and participation; meaningful gains can occur even if pain is not eliminated.
Clinical pearl and summary
- A neuropathic descriptor is a hypothesis to test against examination and medical context, not a license to stop differential diagnosis.
Evidence & Further Reading
These sources are provided so learners can trace the clinical recommendations and read the original guidance.